drugset / Trial / NCT07339748
A Clinical Study of ZL-85FA Tablets
Non-randomizedSequentialOpen-labelPrevention
Summary
An open-label, multicenter phase I/IIa clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZL-85FA tablets in treating advanced solid tumors
Timeline
- Start
- 2026-06-30
- Primary completion
- 2028-06-30
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZL-85FA | Unknown | 2.5 mg | Oral |
| Subject | ZL-85FA | Unknown | 5 mg | Oral |
| Subject | ZL-85FA | Unknown | 10 mg | Oral |
| Subject | ZL-85FA | Unknown | 15 mg | Oral |
| Subject | ZL-85FA | Unknown | 20 mg | Oral |
| Subject | ZL-85FA | Unknown | 25 mg | Oral |
| Subject | ZL-85FA | Unknown | 30 mg | Oral |